Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
Department of Obstetrics, Gynecology and Reproductive Sciences, Center for Reproductive Sciences, University of California, San Francisco, CA 94143, USA.
Mol Hum Reprod. 2021 Jan 22;27(1). doi: 10.1093/molehr/gaaa082.
The etiology and pathogenesis of endometriosis are complex with both genetic and environmental factors contributing to disease risk. Genome-wide association studies (GWAS) have identified multiple signals in the estrogen receptor 1 (ESR1) region associated with endometriosis and other reproductive traits and diseases. In addition, candidate gene association studies identified signals in the ESR1 region associated with endometriosis risk suggesting genetic regulation of genes in this region may be important for reproductive health. This study aimed to investigate hormonal and genetic regulation of genes in the ESR1 region in human endometrium. Changes in serum oestradiol and progesterone concentrations and expression of hormone receptors ESR1 and progesterone receptor (PGR) were assessed in endometrial samples from 135 women collected at various stages of the menstrual cycle. Correlation between hormone concentrations, receptor expression and expression of genes in the ESR1 locus was investigated. The effect of endometriosis risk variants on expression of genes in the region was analyzed to identify gene targets. Hormone concentrations and receptor expression varied significantly across the menstrual cycle. Expression of genes in the ESR1 region correlated with progesterone concentration; however, they were more strongly correlated with expression of ESR1 and PGR suggesting coregulation of genes. There was no evidence that endometriosis risk variants directly regulated expression of genes in the region. Limited sample size and cellular heterogeneity in endometrial tissue may impact the ability to detect significant genetic effects on gene expression. Effects of these variants should be validated in a larger dataset and in relevant individual cell types.
子宫内膜异位症的病因和发病机制复杂,遗传和环境因素都与疾病风险有关。全基因组关联研究(GWAS)已经确定了雌激素受体 1(ESR1)区域与子宫内膜异位症和其他生殖特征和疾病相关的多个信号。此外,候选基因关联研究确定了 ESR1 区域与子宫内膜异位症风险相关的信号,表明该区域基因的遗传调控可能对生殖健康很重要。本研究旨在研究人类子宫内膜中 ESR1 区域基因的激素和遗传调控。在 135 名女性的子宫内膜样本中评估了月经周期各阶段血清雌二醇和孕酮浓度以及激素受体 ESR1 和孕激素受体(PGR)的表达变化。研究了激素浓度、受体表达与 ESR1 基因座基因表达之间的相关性。分析了子宫内膜异位症风险变异对该区域基因表达的影响,以确定基因靶标。激素浓度和受体表达在整个月经周期中变化显著。ESR1 区域基因的表达与孕酮浓度相关;然而,它们与 ESR1 和 PGR 的表达相关性更强,表明基因的共同调控。没有证据表明子宫内膜异位症风险变异直接调节该区域基因的表达。子宫内膜组织中样本量有限和细胞异质性可能会影响检测基因表达中显著遗传效应的能力。应在更大的数据集和相关的单个细胞类型中验证这些变体的影响。